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Abstract
Background: Tanzania is among the 30 countries with the highest tuberculosis (TB) burdens. Because TB has a
long infectious period, early diagnosis is not only important for reducing transmission, but also for improving
treatment outcomes. We assessed diagnostic delay and associated factors among infectious TB patients.
Methods: We interviewed new smear-positive adult pulmonary TB patients enrolled in an ongoing TB cohort study
in Dar es Salaam, Tanzania, between November 2013 and June 2015. TB patients were interviewed to collect
information on socio-demographics, socio-economic status, health-seeking behaviour, and residential geocodes.
We categorized diagnostic delay into ≤ 3 or > 3 weeks. We used logistic regression models to identify risk factors
for diagnostic delay, presented as crude (OR) and adjusted Odds Ratios (aOR). We also assessed association between
geographical distance (incremental increase of 500 meters between household and the nearest pharmacy) with
binary outcomes.
Results: We analysed 513 patients with a median age of 34 years (interquartile range 27–41); 353 (69%) were men.
Overall, 444 (87%) reported seeking care from health care providers prior to TB diagnosis, of whom 211 (48%)
sought care > 2 times. Only six (1%) visited traditional healers before TB diagnosis. Diagnostic delay was positively
associated with absence of chest pain (aOR = 7.97, 95% confidence intervals [CI]: 3.15–20.19; P < 0.001), and
presence of hemoptysis (aOR = 25.37, 95% CI: 11.15–57.74; P < 0.001) and negatively associated with use of
medication prior to TB diagnosis (aOR = 0.31, 95% CI: 0.14–0.71; P = 0.01). Age, sex, HIV status, education level,
household income, and visiting health care facilities (HCFs) were not associated with diagnostic delay. Patients
living far from pharmacies were less likely to visit a HCF (incremental increase of distance versus visit to any facility:
OR = 0.51, 95% CI: 0.28–0.96; P = 0.037).
Conclusions: TB diagnostic delay was common in Dar es Salaam, and was more likely among patients without
prior use of medication and presenting with hemoptysis. Geographical distance to HCFs may have an impact on
health-seeking behaviour. Increasing community awareness of TB signs and symptoms could further reduce
diagnostic delays and interrupt TB transmission.
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Background
Tuberculosis (TB) control remains a major public health
challenge in low-income countries with a high incidence
of TB, particularly where HIV prevalence is also high
[1]. In these settings, TB accounts for approximately
40% of adult deaths. In almost half of these cases, the
disease remains undiagnosed until death [2]. TB patients
are often diagnosed at the later stages of the disease, due
to health-seeking behaviour, inappropriate diagnostic
investigations requested by health care providers, and
limited diagnostic capacities at health care facilities
(HCFs) [3, 4]. Patients experiencing TB symptoms may
initially seek relief by using self-prescribed medication
or by consulting a health care provider who does not
request TB investigations despite repeated visits [5]. The
economic burden of seeking care remains a barrier for
TB patients [6].
Delaying diagnosis and treatment of TB has important
consequences for disease control at both the individual
as well as the community level. At the individual level, a
patient with a delayed diagnosis of TB risks advanced
disease states and worse treatment outcomes. At com-
munity level, a patient with delayed diagnosis is infec-
tious to close contacts; an untreated smear-positive TB
case infects approximately 15 people annually [7, 8].
Delay in seeking care, therefore, promotes continued TB
transmission [9]. The complex pathway to care, from the
onset of symptoms to diagnosis and treatment, may re-
sult in delays in seeking care and contribute to patient
morbidity and mortality [4, 10].
Tanzania is among the 30 countries with the highest
TB burdens [11]. TB case detection in Tanzania largely
relies on passive case detection when patients present
themselves to HCFs, which likely leads to longer diag-
nostic delays [12]. The first national TB prevalence sur-
vey in Tanzania in 2012 showed that only 30% of people
with TB symptoms sought health care and almost half of
these did not undergo diagnostic procedures for TB [4].
To better understand this situation, we studied the extent
of diagnostic delay of TB, its associated risk factors and
factors contributing to health-seeking behaviour among
newly diagnosed smear-positive adult pulmonary TB
(PTB) patients in Dar es Salaam, an urban region in
Tanzania with a high TB burden.
Methods
Study setting and study population
We collected data from an ongoing prospective cohort
of smear-positive adult PTB patients (≥18 years) in
Dar es Salaam, Tanzania (TB-DAR). TB-DAR was ini-
tiated in November 2013 to study the epidemiology
and molecular epidemiology of TB in the densely
populated Temeke district in Tanzania’s commercial
capital, Dar es Salaam. Dar es Salaam, with a popula-
tion of about 4.4 million and rapid urbanization [13],
accounted for nearly 22% of the 65 732 TB cases noti-
fied in 2013 to the National Tuberculosis and Leprosy
Programme (NTLP) in Tanzania [14, 15]. The Temeke
district has approximately 1.4 million people and re-
ported 4,373 TB cases in 2014 [15]. The main sources
of income in the district are food crop sales and small
businesses [16].
Eligibility criteria for TB-DAR study participants were
as follows: 1) ≥18 years of age at recruitment, 2) sputum
microscopy smear-positive TB (quantification grading at
least scanty), 3) residency in Wailes I and II sub-districts
of Temeke and 4) attends the TB clinic at the Temeke
District Hospital or one of its associated TB satellite
treatment centers, Tambukareli and Pasada. Patients
with confirmed TB were started on standard TB treat-
ment regimen within 1 day of diagnosis, as per the na-
tional guidelines [17]. Diagnostic and treatment services
for TB are provided free of charge by the NTLP.
For this analysis, we included newly diagnosed smear-
positive adult PTB cases who were enrolled between
November 2013 and June 2015. The selection of eligible
patients is shown in Fig. 1. Of the 525 smear-positive
PTB patients enrolled in the TB-DAR Study during this
time period, we excluded 12 (2.3%) patients for the
following reasons: 10 (2%) relapse patients, 1 (0.2%) loss
to follow-up and 1 (0.2%) treatment failure (Fig. 1).
Fig. 1 Flow chart of patient selection
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According to the national guidelines [17], presumptive
PTB cases (outpatient or inpatient) are counseled to
bring sputum samples to the laboratory; patients with a
smear-positive result or smear-negative TB cases with
clinical features suggestive of TB (and/or based on add-
itional tests such as chest X-ray) are immediately started
on TB treatment.
Data collection and definitions
Clinical officers with extensive experience in clinical re-
search interviewed patients using standardized question-
naires [18]. Officers collected data on socio-demographic
and socio-economic characteristics and on health-seeking
behaviour at the time of enrolment. In ascertaining signs
and symptoms suggestive of TB, we posed specific ques-
tions (patient ever having felt sick of any symptom such as
coughing, chest pain, fever, weight loss, hemoptysis, night
sweats) and patients were asked to recall the duration of
symptoms (in weeks) [19]. Duration of diagnostic delay
was calculated based on the longest reported TB-related
symptom.
A new adult TB case was defined as a patient aged ≥
18 years with newly diagnosed smear-positive (at least
scanty) pulmonary TB. Sputum microscopy was per-
formed using fluorescent light-emitting diode (LED)
microscopy and the quantitative scoring system was
based on the number of acid-fast bacilli (AFB) accord-
ing to the national guidelines [17, 20]: scanty, 1+, 2+,
and 3+. Diagnostic delay was defined as the time from
onset of any TB-related symptom (patient ever having
felt sick of any symptom such as coughing, chest pain,
fever, weight loss, hemoptysis and night sweat) until the
time of TB diagnosis [3, 19, 21, 22]. Health Care Facil-
ities (HCFs) were defined as places that provide health
care, including hospitals, health centers and dispensar-
ies. Prior medication was defined as the use of any self-
prescribed or prescribed medication prior to TB diag-
nosis and any medication other than anti-TB, antiretro-
viral therapy (ART) or co-trimoxazole (for patients co-
infected with HIV). Multiple HCF visits were defined as
seeking health care from formal health providers more
than twice.
Statistical analysis
Descriptive analyses were performed to summarize the
data. For the purpose of this study, we categorized diag-
nostic delay into two categories: 3 weeks or less and
more than 3 weeks. We considered 3 weeks as a cutoff
for diagnostic delay based on the distribution of the delay
in our study population (Additional file 2: Figure S1) and
the range of diagnostic delay reported in a systematic
review [23]. Associations between dependent variables
(delay of ≤ 3 and > 3 weeks) and independent variables
(such as age, sex, occupation, household income, household
size, TB symptoms, prior use of medication, and number of
HCF visits) were analyzed using logistic regression models.
Variables were included in the multivariate model if
thought to be clinically or socially relevant or had a P-value
of < 0.05 following univariate analysis. Result are presented
as crude (OR) and adjusted odds ratios (aOR). All analyses
were performed in STATA software version 13.1 (Stata
Corporation, Collage Station, Texas, USA).
Geographical analysis
We collected geocodes using Android tablets (Sam-
sung) for all known pharmacies, dispensaries (public/
private), and hospitals, identified during extensive field-
work in the study area. In addition, all study partici-
pants’ households were geocoded. We generated maps
using the open source software QGIS version 2.10.1
[24]. We then calculated the Euclidean distances in me-
ters as a linear distance matrix between participants’
households and the nearest pharmacy. The resulting
Euclidean distances were then imported into STATA
software for further analyses. To overcome separation
in conventional logistic models, we created penalized
likelihood models using the firth logit command in
STATA and assessed the association between an incre-
mental increase of 500 meters (distance between house-
hold and the nearest pharmacy) with binary outcomes
(prior use of medication, diagnostic delay and any visit
to a HCF) [25]. Results were presented as unadjusted
ORs (Fig. 3).
Results
Patient characteristics
We analysed 513 newly diagnosed smear-positive adult
PTB patients. The median age was 34 years (interquar-
tile range [IQR]: 27–41 years, range 18–79); 353 (69%)
were men and 147 (29%) were HIV-positive (Table 1).
The proportion of HIV was higher among women com-
pared to men (43%, versus 22%; P < 0.001). Of the 147
HIV-positive patients, 37 (25%) were on ART prior to
TB diagnosis and 86 (59%) started ART within 7 weeks
of TB diagnosis; ART information was unknown for 24
(16%) patients. Overall, 92 patients (18%) had no formal
education. More than half of the patients (341; 66%)
were semi-skilled workers. Most patients lived in rented
houses (288; 56%). The median household size was three
persons (IQR: 2–4 persons) and 408 (80%) patients
earned < 200 USD per month.
The most commonly reported symptom was coughing
(511 patients; 99.6%), followed by weight loss (493; 96%),
night sweats (487; 94%), fever (475; 93%), chest pain
(411; 80%), and hemoptysis (147; 29%) (Table 1). The
median duration of cough was 3 weeks (IQR: 3.0–3.0).
All other symptoms had a median duration of 2 weeks
(IQR: 1.0–3.0).
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Table 1 Patient characteristics of new smear-positive adult pulmonary tuberculosis (TB) cases in the Temeke District, Dar es Salaam,
Tanzania
Variable All Delay duration Prior medication HC facility visits
n = 513 (weeks)
n (%) ≤ 3 > 3 Not used Used ≤ 2 visits > 2 visits
Total 513 (100) 406 (79) 107 (21) 52 (10) 461 (90) 297 (58) 216 (42)
Age, years
18–24 91 (18) 73 (18) 18 (17) 6 (12) 85 (18) 58 (20) 33 (15)
25–45 333 (65) 264 (65) 69 (64) 37 (71) 296 (64) 199 (67) 134 (59)
> 45 89 (17) 69 (17) 20 (19) 9 (17) 80 (17) 40 (13) 49 (23)
Sex
Male 353 (69) 280 (69) 73 (68) 38 (73) 315 (68) 209 (70) 144 (67)
Female 160 (31) 126 (31) 34 (32) 14 (27) 146 (32) 88 (30) 72 (33)
HIV status
Positive 146 (28) 119 (29) 27 (25) 16 (31) 130 (28) 73 (25) 73 (34)
Negative 367 (72) 287 (71) 80 (75) 36 (69) 331 (72) 224 (75) 143 (66)
Education
No education 92 (18) 73 (18) 19 (18) 8 (15) 84 (18) 46 (15) 46 (21)
Primary/Secondary 404 (79) 316 (78) 88 (82) 44 (85) 360 (78) 243 (82) 161 (75)
University 17 (3) 17 (4) 0 (0) 0 (0) 17 (4) 8 (3) 9 (4)
Occupation
Unemployed or h/wife 103 (20) 86 (21) 17 (16) 4 (8) 99 (21) 46 (15) 57 (26)
Unskilled labour 69 (13) 52 (13) 17 (16) 11 (21) 58 (13) 38 (13) 31 (14)
Semiskilled labour 341 (67) 268 (66) 73 (68) 37 (71) 304 (66) 213 (72) 128 (60)
Household income
< $200 per month 408 (80) 329 (81) 79 (74) 37 (71) 371 (80) 225 (76) 183 (85)
≥ $200 per month 105 (20) 77 (19) 28 (26) 15 (29) 90 (20) 72 (24) 33 (15)
BMI category, kg/m2
< 18.5 36 (7) 29 (7) 7 (7) 3 (6) 33 (7) 25 (8) 11 (5)
18–24.9 273 (53) 204 (50) 69 (64) 20 (38) 253 (55) 163 (55) 110 (51)
25–29.9 154 (30) 129 (32) 25 (23) 19 (37) 135 (29) 78 (26) 76 (35)
> 30 50 (210) 44 (11) 6 (6) 10 (19) 40 (9) 31 (11) 19 (9)
Household size, persons
≥ 4 137 (27) 123 (30) 14 (13) 3 (6) 134 (29) 56 (19) 81 (37)
2–3 331 (64) 256 (63) 75 (70) 43 (83) 288 (63) 208 (70) 123 (57)
Single 45 (9) 27 (7) 18 (17) 6 (12) 39 (8) 33 (11) 12 (6)
House ownership
Own 225 (44) 178 (79) 47 (21) 17 (33) 208 (45) 127 (43) 98 (45)
Rented 288 (56) 228 (79) 60 (21) 35 (67) 253 (55) 170 (57) 118 (55)
Coughing
No 2 (0.5) 2 (0.5) 0 0 (0) 2 (0.4) 1 (0.3) 1 (0.5)
Yes 511 (99.5) 404 (99.5) 107 (100) 52 (100) 459 (99.6) 296 (99.7) 215 (99.5)
Fever
No 38 (7) 37 (9) 1 (1) 3 (6) 35 (8) 33 (11) 5 (2)
Yes 475 (93) 369 (91) 106 (99) 49 (94) 426 (92) 264 (89) 211 (98)
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Health-seeking behaviour and diagnostic delay
About 444 (87%) patients reported seeking care from at
least one of the formal health care providers; of these,
211 (48%) sought care at a HCF three times or more in
relation to TB symptoms prior to TB diagnosis. Only
six (1%) reported to have sought care from traditional
healers and 63 (12%) did not seek care until they pre-
sented to the HCFs of the study recruitment centers,
where they were diagnosed with TB. The median age of
those who sought care three times or more was 35 years
(IQR: 29–44). More men than women sought formal
care three times or more (67% versus 33%). Almost
all patients reported cough (Table 1). The majority of
patients reported having taken medication prior to
TB diagnosis (461 patients; 90%); amoxicillin was the
most common drug of choice (432; 94%), followed by
ciprofloxacin (5; 1%).
The median diagnostic delay time was 3 weeks (IQR:
3.0–3.0, range 1–45 weeks); 28 (5%) patients had a
diagnostic delay of more than 4 weeks. By the third
week of presenting with TB symptoms, 442 (86%)
patients had been diagnosed with the disease. Additional
file 2: Figure S1 shows the distribution of the diagnostic
delay in the study population.
Patient factors associated with diagnostic delay
In the multivariate analysis, diagnostic delay of > 3 weeks
was more likely among patients who did not have chest
pain (aOR = 7.97, 95% CI: 3.15–20.19; P < 0.001), and
who presented with hemoptysis (aOR = 25.37, 95% CI:
11.15–57.74; P < 0.001), and less likely among patients
who used medication prior to TB diagnosis (aOR = 0.31,
95% CI: 0.14–0.71; P = 0.03) as shown in Table 2. Age,
sex, HIV status, occupation, level of income, household
size, and visits to HCF were not associated with diagnostic
delay (Table 2).
Health-seeking behaviour and geographical distance to
pharmacies
The map in Fig. 2 shows the spatial distribution of
pharmacies and HCFs in the study area, and offers ex-
amples of the complex pathways to care until final TB
diagnosis. We counted a total of 35 pharmacies within
the catchment area of the study. The median Euclidean
distance from a participant’s household to the nearest
pharmacy was 412.3 meters (IQR: 254–781, range 6–4
820). More than half of participants’ households (303;
59%) were found within 500 meters of their nearest
pharmacy; 137 (26.7%) were between 500 and 1 000
meters to the nearest pharmacy and only 73 (14.2%)
participants’ households were more than 1 000 meters
away from a pharmacy. For each incremental increase of
500 meters away from a pharmacy, the odds of visiting a
HCF decreased (OR = 0.51, 95% CI: 0.28–0.96; P = 0.037,
comparing patients with any visit to a HCF versus no
visit prior to TB diagnosis, Fig. 3). Geographical distance
did not seem to have an effect on the use of medication
prior to TB diagnosis or on the degree of diagnostic
delay.
Discussion
We studied diagnostic delay among adult infectious TB
patients in an urban district of Dar es Salaam, Tanzania,
with a high TB notification rate. We found that multiple
visits to HCFs and prior use of prescribed or self-
prescribed medication was frequent (41% and 90%) and
that multiple visits were more likely among patients living
closer to HCFs.
We showed that 21% of patients delayed seeking care
for TB symptoms. The median diagnostic delay of 3 weeks
in our study was shorter compared to other delay studies
conducted in sub-Saharan Africa, Asia as well as Eastern
Europe [5, 26–30]. A systematic review from low- and
Table 1 Patient characteristics of new smear-positive adult pulmonary tuberculosis (TB) cases in the Temeke District, Dar es Salaam,
Tanzania (Continued)
Chest pain
No 102 (20) 69 (17) 33 (31) 40 (77) 62 (14) 94 (32) 8 (4)
Yes 411 (80) 337 (83) 74 (69) 12 (23) 399 (87) 203 (68) 208 (96)
Haemoptysis
No 336 (71) 324 (80) 42 (39) 52 (100) 314 (68) 185 (62) 181 (84)
Yes 147 (29) 82 (20) 65 (61) 0 147 (32) 112 (38) 35 (16)
Night sweat
No 26 (5) 25 (6) 1 (1) 1 (2) 25 (5) 24 (8) 2 (1)
Yes 487 (95) 381 (94) 106 (99) 51 (98) 436 (95) 273 (92) 214 (99)
Unexplained weight loss
No 20 (4) 18 (4) 2 (2) 1 (2) 19 (4) 15 (5) 5 (2)
Yes 493 (96) 388 (96) 105 (98) 51 (98) 442 (96) 282 (95) 211 (98)
BMI body mass index, h/wife housewife, TB tuberculosis, HC facility health care facility
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high-income settings reported a median total delay of
3–26 weeks [23]. Our diagnostic delay (time from onset
of symptoms until diagnosis) was also shorter than the
treatment delay (time from onset of symptoms until
treatment) reported in a study conducted in six rural
and urban districts in Tanzania (median treatment
delay time was 10–14.5 weeks) [31]. In our study, we
disregarded the treatment delay because all patients
were strictly put on TB treatment within 1 day of
confirming TB diagnosis, as per the guidelines of the
NTLP.
We found that more than three quarters of patients
sought formal care prior to being diagnosed with TB,
with nearly half of them seeking care more than twice.
This indicates that a high proportion of TB patients is
seen by several different health care providers before
receiving a TB diagnosis, suggesting a low suspicion
index among health care providers. The first national TB
Table 2 Associations of diagnosis delay (defined as > 3 weeks) with socio-demographic and clinical characteristics among new pul-
monary TB patients
Characteristic Cases Unadjusted Adjusted
n (%) OR (95% CI) P-value aOR (95% CI) P-value
Age, years 0.7 0.7
18–24 91 (18) 1 1
25–45 333 (65) 1.06 (0.59–1.89) 0.81 (0.39–1.67)
> 45 189 (17) 1.18 (0.57–2.41) 1.08 (0.44–2.66)
Sex 0.9 0.6
Female 160 (31) 1 1
Male 353 (69) 0.97 (0.61–1.53) 0.84 (0.46–1.51)
HIV status 0.4 0.5
Negative 366 (71) 1 1
Positive 147 (29) 0.81 (0.50–1.30) 0.83 (0.46–1.52)
Occupation 0.4 0.1
Unemployed, or h/wife 103 (20) 1 1
Unskilled labor 69 (13) 1.65 (0.78–3.52) 1.24 (0.48–3.26)
Semiskilled labor 341 (67) 1.38 (0.77–2.46) 0.69 (0.32–1.51)
Household income 0.1 0.3
< $200 per month 408 (80) 1 1
≥ $200 per month 105 (20) 1.51 (0.92–2.49) 1.34 (0.73–2.47)
Household size, persons < 0.001 0.2
≥ 4 137 (27) 1 1
2–3 331 (64) 2.57 (1.40–4.74) 1.38 (0.67–2.83)
Single 45 (9) 5.86 (2.60–13.21) 1.81 (0.71–4.59)
Visits to a HCF < 0.001 0.9
> 2 216 (42) 1 1
≤ 2 297 (58) 3.31 (2.01–5.46) 0.99 (0.52–1.90)
Prior purchase of medication 0.001 0.01
No 52 (10) 1 1
Yes 461 (90) 0.37 (0.20–0.68) 0.31 (0.14–0.71)
Chest pain 0.002 <0.001
Yes 411 (80) 1 1
No 102 (20) 2.18 (1.34–3.54) 7.97 (3.15–20.19)
Hemoptysis <0.001 <0.001
No 366 (71) 1 1
Yes 147 (29) 6.11 (3.87–9.66) 25.37 (11.15–57.74)
OR odds ratio, aOR adjusted odds ratio, 95% CI, 95% confidence interval, h/wife housewife, HCF health care facility
Model was adjusted for age, sex, HIV status, occupation, house hold income, household size, visit to HCF, prior use of medication, chest pain and hemoptysis
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prevalence survey in Tanzania reported that one third of
patients suspected of having TB sought care before the
survey, which confirms that many infectious TB cases
are missed by the health care system in Tanzania [4].
Furthermore, a study from Uganda showed that the
proportion of patients who sought care before being
diagnosed with TB can be as high as 80% [32].
We also found that use of medication prior to TB
diagnosis was associated with shorter diagnostic delays.
This could be explained by the fact that patients who
did not use medication prior to TB diagnosis could not
afford any health care service, feared the stigma of being
known to be sick, or did not have adequate knowledge
about signs and symptoms of TB. Indeed, inadequate
knowledge about TB and stigma has previously been
associated with longer diagnostic delays [3, 23, 33–35].
In contrast, studies from Georgia, Ethiopia and Angola
reported that the use of antibiotics prior to TB diagnosis
was associated with a prolonged delay [5, 36, 37]. This
difference can be explained by the fact that we defined
use of medication as any medication prior to TB diag-
nosis, rather than antibiotics alone, as patients may not
accurately remember the type of medication used in the
past. Furthermore, patients may tend to wait for im-
provement of symptoms before seeking health care in
these specific study settings and countries, but not in
our setting of Dar es Salaam.
Patient factors associated with diagnostic delay may
vary considerably across settings and countries [8, 28,
29, 33, 38–40]. In our study, diagnostic delay was not
reduced among HIV-positive patients despite the widely
implemented TB/HIV collaborative activities by the
National AIDS Control Programme and the NTLP in
Tanzania [17]. We also found that chest pain was associ-
ated with a shorter diagnostic delay, in contrast to studies
from Afghanistan and Brazil [41, 42]. Hemoptysis, which
usually presents at the later stage of disease [43], was
associated with a prolonged delay in our study. Patients
Fig. 2 Geographical analyses of health care facilities (HCFs) and pathways to care of patients with tuberculosis (TB) symptoms in the study area,
Temeke District, Dar es Salaam, Tanzania. Panel a: Localization of the two governmental TB clinics which serve as recruitment sites in the study
area (in red). Panel b: Spatial distribution of pharmacies and HCFs in the study area. Panel c: Five examples of possible pathways to care of patients
with TB symptoms seeking care. Various types of HCFs as the entry point into the health care system (single or multiple visits) until final diagnosis at
the TB clinic are presented
Said et al. Infectious Diseases of Poverty  (2017) 6:64 Page 7 of 10
presenting with hemoptysis may tend to ignore other TB
symptoms until the disease is advanced and hemoptysis
has developed. Systematic reviews reported the opposite
trend, possibly because hemoptysis may necessitate health
care providers to investigate for TB early on [8, 44].
Consistent with our results, previous studies found no
association of diagnostic delay with patients’ sex [33] or
low-income class [8].
We also investigated the impact of the geographical
distance on the health-seeking behaviour of patients
with TB symptoms using geographic information system
(GIS) tools. GIS is increasingly being used to describe
the epidemiology of diseases and to map HCFs for stra-
tegic planning of public health measures [45–47]. We
found that patients living closer to a pharmacy tended to
visit facilities more frequently. This suggests that the
availability of health care services (public/private) affects
use by the resident population. In line with our results, a
study from Tanzania showed that residing at a distance
of more than 5 km from a TB diagnostic center was
associated with diagnostic delay [29]. In addition, a
systematic review found that a longer walking distance
to a HCF was correlated with patient delay, defined as
the time from onset of the first TB symptoms (usually
described as the onset of persistent coughing) until the
date of the first HCF consultation [44].
Our study has several limitations. First, we had to rely
on patients’ recall of previous interactions with the health
care system. This could have introduced a recall bias influ-
encing the accuracy of the data. However, our interviewers
were well trained in patient interviews and experienced in
conducting scientific studies. Therefore, the collected in-
formation was likely to be accurate. Second, our findings
may be specific to urban settings in Tanzania such as Dar
es Salaam as well as to the study period and, therefore,
may not be generalizable. Finally, we did not collect de-
tailed information on the pathway to care at the individual
level, such as dates and types of HCF visited, patients’
reasons for delay or socio-cultural factors underlying the
delay in seeking care.
Conclusions
In conclusion, we found that TB diagnostic delay was
common in urban Tanzania, possibly due to passive case
detection practice. We also found that the use of medica-
tion prior to TB diagnosis was common, which potentially
poses challenges in the rational use of medication. Since
many patients repeatedly accessed health care services
before being diagnosed with TB, our study re-emphasizes
the need for improved diagnostic capacities, as well as
training and re-training of health care workers to increase
awareness and timely diagnosis of TB. Consequent sys-
tematic screening for TB at HCFs at any care level could
further reduce the diagnostic delay to interrupt TB trans-
mission in the community. To support the implementa-
tion of active case detection interventions, future research
should focus on health-seeking behaviour and how it is
affected by cost factors and by the role of socio-cultural
and other community determinants [12, 48–50].
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Fig. 3 Association between health-seeking behaviour and geographical
distances to pharmacies. The regression coefficient plot (with
corresponding 95% confidence intervals) shows the association
of the Euclidean distance between participants’ households to the
nearest pharmacy with purchase of medication prior to TB diagnosis,
diagnostic delay (> 3 weeks), and visit of any HCF before TB diagnosis.
Odds Ratios (OR) above 1 indicate that the factor is more likely with
increasing distance away from the nearest pharmacy, and an OR
below 1 that the factor is more likely the closer the household is to
a pharmacy. HCF, health care facility
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